OCLN Human (R)-carnitine multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Carnitine inhibits the reaction [carbendazim results in decreased expression of OCLN protein] CTD PMID:33965443 OCLN Human (S)-amphetamine increases expression ISO Ocln (Mus musculus) 6480464 Dextroamphetamine results in increased expression of OCLN mRNA CTD PMID:12205029 OCLN Human (S)-amphetamine multiple interactions ISO Ocln (Mus musculus) 6480464 SOD1 inhibits the reaction [Dextroamphetamine results in increased expression of OCLN mRNA] CTD PMID:12205029 OCLN Human (S)-colchicine decreases expression ISO Ocln (Mus musculus) 6480464 Colchicine results in decreased expression of OCLN mRNA CTD PMID:33002524 OCLN Human 1,10-phenanthroline multiple interactions EXP 6480464 1 and 10-phenanthroline inhibits the reaction [Patulin results in increased degradation of OCLN protein] CTD PMID:19013514 OCLN Human 1,2-dichloroethane decreases expression ISO Ocln (Mus musculus) 6480464 ethylene dichloride results in decreased expression of OCLN protein CTD PMID:30081051 OCLN Human 1,2-dichloroethane multiple interactions ISO Ocln (Mus musculus) 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ethylene dichloride results in decreased expression of OCLN protein] more ... CTD PMID:30081051 and PMID:30664321 OCLN Human 1,2-dichloroethane increases expression ISO Ocln (Mus musculus) 6480464 ethylene dichloride results in increased expression of OCLN mRNA CTD PMID:28960355 OCLN Human 1,2-dimethylhydrazine decreases expression ISO Ocln (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of OCLN mRNA CTD PMID:22206623 OCLN Human 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO Ocln (Mus musculus) 6480464 [Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 OCLN Human 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO Ocln (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:31351185 OCLN Human 1-naphthyl isothiocyanate multiple interactions ISO Ocln (Mus musculus) 6480464 acadesine promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of OCLN protein] more ... CTD PMID:32579994 and PMID:33400020 OCLN Human 1-naphthyl isothiocyanate decreases expression ISO Ocln (Mus musculus) 6480464 1-Naphthylisothiocyanate results in decreased expression of OCLN mRNA and 1-Naphthylisothiocyanate results in decreased expression of OCLN protein CTD PMID:32579994 and PMID:33400020 OCLN Human 17beta-estradiol multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Estradiol promotes the reaction [bisphenol A results in decreased expression of OCLN mRNA] CTD PMID:27174447 OCLN Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of OCLN mRNA CTD PMID:30165855 OCLN Human 17beta-estradiol 17-glucosiduronic acid affects localization ISO Ocln (Rattus norvegicus) 6480464 estradiol-17 beta-glucuronide affects the localization of OCLN protein CTD PMID:17463180 OCLN Human 17beta-estradiol 3-benzoate multiple interactions ISO Ocln (Rattus norvegicus) 6480464 fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of OCLN mRNA] CTD PMID:19433574 OCLN Human 17beta-estradiol 3-benzoate increases expression ISO Ocln (Rattus norvegicus) 6480464 estradiol 3-benzoate results in increased expression of OCLN mRNA and estradiol 3-benzoate results in increased expression of OCLN protein CTD PMID:19433574 OCLN Human 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of OCLN mRNA] and fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of OCLN protein] CTD PMID:19433574 OCLN Human 17beta-estradiol 3-benzoate increases expression EXP 6480464 estradiol 3-benzoate results in increased expression of OCLN mRNA and estradiol 3-benzoate results in increased expression of OCLN protein CTD PMID:19433574 OCLN Human 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:20299304 OCLN Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Ocln (Mus musculus) 6480464 2 more ... CTD PMID:20064788 OCLN Human 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO Ocln (Rattus norvegicus) 6480464 2 more ... CTD PMID:20299304 OCLN Human 2,3',4,4',5-Pentachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:20299304 OCLN Human 2,3',4,4',5-Pentachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:22906770 OCLN Human 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO Ocln (Rattus norvegicus) 6480464 2 more ... CTD PMID:20299304 OCLN Human 2,3',4,4',5-Pentachlorobiphenyl multiple interactions ISO Ocln (Mus musculus) 6480464 2 more ... CTD PMID:20064788 OCLN Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of OCLN mRNA CTD PMID:23152189 OCLN Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ocln (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of OCLN mRNA CTD PMID:33387578 OCLN Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ocln (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of OCLN mRNA CTD PMID:33956508 OCLN Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ocln (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OCLN mRNA CTD PMID:25975270 OCLN Human 2,3-bis(4-hydroxyphenyl)propionitrile multiple interactions EXP 6480464 Fulvestrant inhibits the reaction [2 more ... CTD PMID:19433574 OCLN Human 2,3-bis(4-hydroxyphenyl)propionitrile increases expression EXP 6480464 2 more ... CTD PMID:19433574 OCLN Human 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO Ocln (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA and Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein CTD PMID:22147983 more ... OCLN Human 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO Ocln (Rattus norvegicus) 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA and Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein CTD PMID:35290143 OCLN Human 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Ocln (Rattus norvegicus) 6480464 oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA] more ... CTD PMID:35290143 OCLN Human 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Ocln (Mus musculus) 6480464 Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA] and ginsenoside Re inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein] CTD PMID:22849695 and PMID:25307695 OCLN Human 2,4-D decreases expression ISO Ocln (Rattus norvegicus) 6480464 2 and 4-Dichlorophenoxyacetic Acid results in decreased expression of OCLN mRNA CTD PMID:28699141 OCLN Human 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of OCLN mRNA more ... CTD PMID:36414212 OCLN Human 2-palmitoylglycerol increases expression EXP 6480464 2-palmitoylglycerol results in increased expression of OCLN mRNA CTD PMID:37199045 OCLN Human 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO Ocln (Mus musculus) 6480464 3 more ... CTD PMID:20064788 and PMID:37598416 OCLN Human 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Ocln (Mus musculus) 6480464 3 more ... CTD PMID:37598416 OCLN Human 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Ocln (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 OCLN Human 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20299304 OCLN Human 3,3',5-triiodo-L-thyronine increases expression ISO Ocln (Rattus norvegicus) 6480464 Triiodothyronine results in increased expression of OCLN mRNA CTD PMID:15953391 OCLN Human 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions EXP 6480464 bisindolylmaleimide I inhibits the reaction [Cadmium Chloride affects the localization of OCLN protein] more ... CTD PMID:25851441 and PMID:28780155 OCLN Human 4,4'-sulfonyldiphenol multiple interactions ISO Ocln (Mus musculus) 6480464 [bisphenol S co-treated with Tretinoin] results in decreased expression of OCLN mRNA CTD PMID:30951980 OCLN Human 4,4'-sulfonyldiphenol increases expression ISO Ocln (Mus musculus) 6480464 bisphenol S results in increased expression of OCLN mRNA CTD PMID:30951980 OCLN Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of OCLN protein CTD PMID:30236600 OCLN Human 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression EXP 6480464 Am 580 results in increased expression of OCLN mRNA CTD PMID:16982755 OCLN Human 4-hydroxyphenyl retinamide increases expression ISO Ocln (Mus musculus) 6480464 Fenretinide results in increased expression of OCLN mRNA CTD PMID:28973697 OCLN Human 4-hydroxyphenyl retinamide decreases expression ISO Ocln (Mus musculus) 6480464 Fenretinide results in decreased expression of OCLN mRNA CTD PMID:28973697 OCLN Human 4-phenylbutyric acid multiple interactions ISO Ocln (Mus musculus) 6480464 4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of OCLN protein] CTD PMID:35533795 OCLN Human 4-tert-Octylphenol decreases expression ISO Ocln (Rattus norvegicus) 6480464 4-tert-octylphenol results in decreased expression of OCLN protein CTD PMID:15082077 OCLN Human 5-azacytidine increases expression EXP 6480464 Azacitidine results in increased expression of OCLN mRNA CTD PMID:18661270 OCLN Human 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:31472180 OCLN Human 6-propyl-2-thiouracil increases expression ISO Ocln (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of OCLN mRNA CTD PMID:24780913 OCLN Human 7,8-dihydroxycoumarin multiple interactions ISO Ocln (Mus musculus) 6480464 daphnetin inhibits the reaction [Dextran Sulfate results in decreased expression of OCLN protein] CTD PMID:37209277 OCLN Human acadesine multiple interactions ISO Ocln (Mus musculus) 6480464 acadesine promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of OCLN protein] CTD PMID:33400020 OCLN Human acetaldehyde multiple interactions EXP 6480464 EGF protein inhibits the reaction [Acetaldehyde affects the localization of OCLN protein] and PLCG1 protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of OCLN protein]] CTD PMID:17991733 OCLN Human acetaldehyde affects localization EXP 6480464 Acetaldehyde affects the localization of OCLN protein CTD PMID:22563376 OCLN Human acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester multiple interactions ISO Ocln (Mus musculus) 6480464 nitazoxanide inhibits the reaction [Dextran Sulfate results in decreased expression of OCLN protein] CTD PMID:38663798 OCLN Human acrylonitrile decreases expression EXP 6480464 Acrylonitrile results in decreased expression of OCLN protein CTD PMID:30236600 OCLN Human actinidine increases cleavage EXP 6480464 actinidine results in increased cleavage of OCLN protein CTD PMID:25042511 OCLN Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of OCLN mRNA CTD PMID:22100608 and PMID:27153755 OCLN Human aflatoxin B1 decreases expression ISO Ocln (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of OCLN protein CTD PMID:33421461 OCLN Human aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of OCLN intron CTD PMID:30157460 OCLN Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of OCLN gene CTD PMID:27153756 OCLN Human aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of OCLN mRNA and Glucose results in decreased expression of OCLN protein CTD PMID:21617913 more ... OCLN Human aldehydo-D-glucose multiple interactions EXP 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 OCLN Human aldehydo-D-glucose decreases expression ISO Ocln (Mus musculus) 6480464 Glucose results in decreased expression of OCLN protein CTD PMID:21617913 OCLN Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of OCLN mRNA CTD PMID:16982755 OCLN Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of OCLN mRNA CTD PMID:33167477 OCLN Human all-trans-retinoic acid multiple interactions ISO Ocln (Mus musculus) 6480464 [bisphenol S co-treated with Tretinoin] results in decreased expression of OCLN mRNA CTD PMID:30951980 OCLN Human alpha,alpha-trehalose multiple interactions ISO Ocln (Mus musculus) 6480464 Trehalose inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 OCLN Human alpha-D-galactose decreases expression ISO Ocln (Mus musculus) 6480464 Galactose results in decreased expression of OCLN protein CTD PMID:33516661 OCLN Human Alpinetin multiple interactions EXP 6480464 alpinetin inhibits the reaction [TNF protein results in decreased expression of OCLN mRNA] CTD PMID:31676321 OCLN Human ammonium chloride affects expression ISO Ocln (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of OCLN mRNA CTD PMID:16483693 OCLN Human Ammothamnine multiple interactions ISO Ocln (Rattus norvegicus) 6480464 oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA] and oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein] CTD PMID:35290143 OCLN Human ampicillin multiple interactions ISO Ocln (Mus musculus) 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA] and [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein] CTD PMID:35390362 OCLN Human arsane multiple interactions EXP 6480464 Arsenic affects the phosphorylation of and results in increased expression of OCLN protein CTD PMID:24349408 OCLN Human arsane decreases expression ISO Ocln (Rattus norvegicus) 6480464 Arsenic results in decreased expression of OCLN mRNA CTD PMID:28829631 OCLN Human arsane affects methylation EXP 6480464 Arsenic affects the methylation of OCLN gene CTD PMID:25304211 OCLN Human arsane increases expression EXP 6480464 Arsenic results in increased expression of OCLN protein CTD PMID:24349408 OCLN Human arsane affects localization ISO Ocln (Mus musculus) 6480464 Arsenic affects the localization of OCLN protein CTD PMID:24349408 OCLN Human arsenic atom affects localization ISO Ocln (Mus musculus) 6480464 Arsenic affects the localization of OCLN protein CTD PMID:24349408 OCLN Human arsenic atom decreases expression ISO Ocln (Rattus norvegicus) 6480464 Arsenic results in decreased expression of OCLN mRNA CTD PMID:28829631 OCLN Human arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of OCLN gene CTD PMID:25304211 OCLN Human arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of OCLN protein CTD PMID:24349408 OCLN Human arsenic atom multiple interactions EXP 6480464 Arsenic affects the phosphorylation of and results in increased expression of OCLN protein CTD PMID:24349408 OCLN Human arsenite(3-) multiple interactions ISO Ocln (Mus musculus) 6480464 [Arsenic Trioxide results in increased abundance of arsenite] which results in decreased expression of OCLN mRNA CTD PMID:36791901 OCLN Human arsenite(3-) decreases expression ISO Ocln (Mus musculus) 6480464 arsenite results in decreased expression of OCLN mRNA and arsenite results in decreased expression of OCLN protein CTD PMID:37442281 OCLN Human arsenous acid decreases expression ISO Ocln (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of OCLN mRNA and Arsenic Trioxide results in decreased expression of OCLN protein CTD PMID:30032600 more ... OCLN Human arsenous acid multiple interactions ISO Ocln (Mus musculus) 6480464 [Arsenic Trioxide results in increased abundance of arsenite] which results in decreased expression of OCLN mRNA more ... CTD PMID:36473683 and PMID:36791901 OCLN Human arsenous acid multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein] more ... CTD PMID:32683294 OCLN Human arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of OCLN mRNA and Arsenic Trioxide results in decreased expression of OCLN protein CTD PMID:32683294 OCLN Human benzalkonium chloride decreases expression ISO Ocln (Mus musculus) 6480464 Benzalkonium Compounds results in decreased expression of OCLN protein CTD PMID:29514330 OCLN Human benzo[a]pyrene decreases expression ISO Ocln (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of OCLN mRNA CTD PMID:22228805 OCLN Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of OCLN protein CTD PMID:30236600 OCLN Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of OCLN 5' UTR and Benzo(a)pyrene affects the methylation of OCLN promoter CTD PMID:27901495 OCLN Human beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of OCLN mRNA CTD PMID:32151702 OCLN Human biochanin A multiple interactions ISO Ocln (Mus musculus) 6480464 biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of OCLN protein] CTD PMID:38648921 OCLN Human bis(2-chloroethyl) sulfide increases expression ISO Ocln (Mus musculus) 6480464 Mustard Gas results in increased expression of OCLN mRNA CTD PMID:15674843 OCLN Human bis(2-ethylhexyl) phthalate decreases expression ISO Ocln (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of OCLN mRNA and Diethylhexyl Phthalate results in decreased expression of OCLN protein CTD PMID:36209858 more ... OCLN Human bis(2-ethylhexyl) phthalate multiple interactions ISO Ocln (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of OCLN protein CTD PMID:37364641 OCLN Human bisphenol A decreases expression ISO Ocln (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of OCLN mRNA and bisphenol A results in decreased expression of OCLN protein CTD PMID:15082077 more ... OCLN Human bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of OCLN gene CTD PMID:31601247 OCLN Human bisphenol A multiple interactions ISO Ocln (Mus musculus) 6480464 4-methyl-N1-(3-phenylpropyl)benzene-1 more ... CTD PMID:33485121 and PMID:37364641 OCLN Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of OCLN protein CTD PMID:32559890 OCLN Human bisphenol A increases expression ISO Ocln (Rattus norvegicus) 6480464 bisphenol A results in increased expression of OCLN mRNA CTD PMID:32145629 OCLN Human bisphenol A decreases expression ISO Ocln (Mus musculus) 6480464 bisphenol A results in decreased expression of OCLN mRNA and bisphenol A results in decreased expression of OCLN protein CTD PMID:30951980 more ... OCLN Human bisphenol A multiple interactions ISO Ocln (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of and affects the localization of OCLN protein and Estradiol promotes the reaction [bisphenol A results in decreased expression of OCLN mRNA] CTD PMID:19497385 and PMID:27174447 OCLN Human bisphenol A affects expression ISO Ocln (Rattus norvegicus) 6480464 bisphenol A affects the expression of OCLN mRNA CTD PMID:25181051 OCLN Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of OCLN protein CTD PMID:26922907 OCLN Human bisphenol A increases expression ISO Ocln (Mus musculus) 6480464 bisphenol A results in increased expression of OCLN mRNA CTD PMID:22435627 more ... OCLN Human bisphenol F increases expression ISO Ocln (Mus musculus) 6480464 bisphenol F results in increased expression of OCLN mRNA CTD PMID:30951980 OCLN Human bisphenol F decreases expression ISO Ocln (Mus musculus) 6480464 bisphenol F results in decreased expression of OCLN mRNA CTD PMID:35278557 OCLN Human busulfan multiple interactions ISO Ocln (Mus musculus) 6480464 4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of OCLN protein] CTD PMID:35533795 OCLN Human busulfan decreases expression ISO Ocln (Mus musculus) 6480464 Busulfan results in decreased expression of OCLN mRNA and Busulfan results in decreased expression of OCLN protein CTD PMID:35533795 OCLN Human Butylbenzyl phthalate multiple interactions ISO Ocln (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of OCLN protein CTD PMID:37364641 OCLN Human butyric acid multiple interactions ISO Ocln (Mus musculus) 6480464 Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] CTD PMID:29751049 OCLN Human butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of OCLN mRNA CTD PMID:36473683 OCLN Human cadmium atom decreases expression ISO Ocln (Rattus norvegicus) 6480464 Cadmium results in decreased expression of OCLN mRNA CTD PMID:28829631 OCLN Human cadmium atom multiple interactions ISO Ocln (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OCLN mRNA CTD PMID:37325564 OCLN Human cadmium atom multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OCLN mRNA more ... CTD PMID:31390532 OCLN Human cadmium dichloride decreases expression ISO Ocln (Rattus norvegicus) 6480464 Cadmium Chloride results in decreased expression of OCLN protein CTD PMID:15618353 OCLN Human cadmium dichloride multiple interactions ISO Ocln (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OCLN mRNA CTD PMID:37325564 OCLN Human cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of OCLN mRNA CTD PMID:38568856 OCLN Human cadmium dichloride increases phosphorylation EXP 6480464 Cadmium Chloride results in increased phosphorylation of OCLN protein CTD PMID:25851441 OCLN Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of OCLN mRNA CTD PMID:25851441 OCLN Human cadmium dichloride multiple interactions EXP 6480464 bisindolylmaleimide I inhibits the reaction [Cadmium Chloride affects the localization of OCLN protein] more ... CTD PMID:25851441 OCLN Human cadmium dichloride multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OCLN mRNA more ... CTD PMID:15618353 and PMID:31390532 OCLN Human caffeine affects phosphorylation EXP 6480464 Caffeine affects the phosphorylation of OCLN protein CTD PMID:35688186 OCLN Human calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of OCLN mRNA CTD PMID:26485663 OCLN Human calcium atom multiple interactions EXP 6480464 Calcium deficiency inhibits the reaction [TJP1 protein binds to OCLN protein] CTD PMID:11054866 OCLN Human calcium(0) multiple interactions EXP 6480464 Calcium deficiency inhibits the reaction [TJP1 protein binds to OCLN protein] CTD PMID:11054866 OCLN Human carbendazim decreases expression ISO Ocln (Rattus norvegicus) 6480464 carbendazim results in decreased expression of OCLN protein CTD PMID:33965443 OCLN Human carbendazim multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Carnitine inhibits the reaction [carbendazim results in decreased expression of OCLN protein] CTD PMID:33965443 OCLN Human carbon nanotube increases expression ISO Ocln (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 OCLN Human carbon nanotube decreases expression ISO Ocln (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 and PMID:32413421 OCLN Human chlorogenic acid multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OCLN mRNA] and Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OCLN protein] CTD PMID:31390532 OCLN Human chloroquine increases expression EXP 6480464 Chloroquine results in increased expression of OCLN mRNA CTD PMID:25752684 OCLN Human chlorothalonil decreases expression EXP 6480464 tetrachloroisophthalonitrile results in decreased expression of OCLN mRNA CTD PMID:34549778 OCLN Human chlorpyrifos increases expression ISO Ocln (Rattus norvegicus) 6480464 Chlorpyrifos results in increased expression of OCLN mRNA CTD PMID:25019507 OCLN Human chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of OCLN mRNA CTD PMID:36167171 OCLN Human chlorpyrifos multiple interactions ISO Ocln (Mus musculus) 6480464 VEGFA protein promotes the reaction [Chlorpyrifos results in increased expression of OCLN protein] CTD PMID:37263558 OCLN Human chlorpyrifos decreases expression ISO Ocln (Rattus norvegicus) 6480464 Chlorpyrifos results in decreased expression of OCLN mRNA CTD PMID:34075131 OCLN Human choline multiple interactions ISO Ocln (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of OCLN and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OCLN gene CTD PMID:20938992 OCLN Human chromium(6+) decreases expression ISO Ocln (Rattus norvegicus) 6480464 chromium hexavalent ion results in decreased expression of OCLN mRNA and chromium hexavalent ion results in decreased expression of OCLN protein CTD PMID:32679048 OCLN Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of OCLN mRNA CTD PMID:27392435 OCLN Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of OCLN mRNA CTD PMID:27392435 OCLN Human clopidogrel decreases expression EXP 6480464 clopidogrel results in decreased expression of OCLN protein CTD PMID:23220562 OCLN Human clopidogrel multiple interactions EXP 6480464 SB 203580 inhibits the reaction [clopidogrel results in decreased expression of OCLN protein] CTD PMID:23220562 OCLN Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of OCLN protein CTD PMID:19324842 OCLN Human cobalt dichloride decreases expression ISO Ocln (Mus musculus) 6480464 cobaltous chloride results in decreased expression of OCLN protein CTD PMID:21617913 OCLN Human copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of OCLN mRNA CTD PMID:20971185 OCLN Human copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of OCLN mRNA CTD PMID:20971185 OCLN Human cordycepin increases expression ISO Ocln (Mus musculus) 6480464 cordycepin results in increased expression of OCLN mRNA CTD PMID:32042022 OCLN Human corticosterone multiple interactions ISO Ocln (Mus musculus) 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein and Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] CTD PMID:29751049 OCLN Human cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of OCLN mRNA CTD PMID:25763180 OCLN Human curcumin multiple interactions ISO Ocln (Mus musculus) 6480464 Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of OCLN mRNA] and Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein] CTD PMID:35817260 OCLN Human cyclophosphamide multiple interactions ISO Ocln (Mus musculus) 6480464 Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of OCLN protein] CTD PMID:32151603 OCLN Human cyclophosphamide multiple interactions ISO Ocln (Rattus norvegicus) 6480464 O-1602 compound inhibits the reaction [Cyclophosphamide results in increased expression of OCLN protein] CTD PMID:32615180 OCLN Human cyclophosphamide increases expression ISO Ocln (Rattus norvegicus) 6480464 Cyclophosphamide results in increased expression of OCLN protein CTD PMID:32615180 OCLN Human cyclophosphamide decreases expression ISO Ocln (Mus musculus) 6480464 Cyclophosphamide results in decreased expression of OCLN protein CTD PMID:32151603 OCLN Human D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of OCLN mRNA and Glucose results in decreased expression of OCLN protein CTD PMID:21617913 more ... OCLN Human D-glucose multiple interactions EXP 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 OCLN Human D-glucose decreases expression ISO Ocln (Mus musculus) 6480464 Glucose results in decreased expression of OCLN protein CTD PMID:21617913 OCLN Human DDE decreases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of OCLN mRNA CTD PMID:38568856 OCLN Human decabromodiphenyl ether multiple interactions EXP 6480464 Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of OCLN mRNA] and Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of OCLN protein] CTD PMID:33675858 OCLN Human decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of OCLN mRNA and decabromobiphenyl ether results in decreased expression of OCLN protein CTD PMID:33675858 OCLN Human deoxynivalenol affects localization EXP 6480464 deoxynivalenol affects the localization of OCLN protein CTD PMID:24568843 OCLN Human deoxynivalenol decreases expression ISO Ocln (Mus musculus) 6480464 deoxynivalenol results in decreased expression of OCLN mRNA and deoxynivalenol results in decreased expression of OCLN protein CTD PMID:34506767 more ... OCLN Human deoxynivalenol multiple interactions ISO Ocln (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]] more ... CTD PMID:34506767 more ... OCLN Human deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of OCLN mRNA CTD PMID:20362602 and PMID:24568843 OCLN Human Deoxyschizandrin multiple interactions EXP 6480464 schizandrin A inhibits the reaction [Mycophenolic Acid results in decreased expression of OCLN protein] CTD PMID:35321622 OCLN Human dexamethasone multiple interactions ISO Ocln (Mus musculus) 6480464 Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA] CTD PMID:25307695 OCLN Human dexamethasone decreases expression ISO Ocln (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of OCLN mRNA CTD PMID:36790081 OCLN Human dextran sulfate decreases expression ISO Ocln (Mus musculus) 6480464 Dextran Sulfate results in decreased expression of OCLN mRNA and Dextran Sulfate results in decreased expression of OCLN protein CTD PMID:23261717 more ... OCLN Human dextran sulfate multiple interactions ISO Ocln (Mus musculus) 6480464 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in decreased expression of OCLN protein] more ... CTD PMID:27995407 more ... OCLN Human Di-n-octyl phthalate multiple interactions ISO Ocln (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of OCLN protein CTD PMID:37364641 OCLN Human diarsenic trioxide multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein] more ... CTD PMID:32683294 OCLN Human diarsenic trioxide multiple interactions ISO Ocln (Mus musculus) 6480464 [Arsenic Trioxide results in increased abundance of arsenite] which results in decreased expression of OCLN mRNA more ... CTD PMID:36473683 and PMID:36791901 OCLN Human diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of OCLN mRNA and Arsenic Trioxide results in decreased expression of OCLN protein CTD PMID:32683294 OCLN Human diarsenic trioxide decreases expression ISO Ocln (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of OCLN mRNA and Arsenic Trioxide results in decreased expression of OCLN protein CTD PMID:30032600 more ... OCLN Human dibutyl phthalate increases expression ISO Ocln (Rattus norvegicus) 6480464 Dibutyl Phthalate results in increased expression of OCLN mRNA CTD PMID:21266533 OCLN Human dibutyl phthalate multiple interactions ISO Ocln (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of OCLN protein CTD PMID:37364641 OCLN Human diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of OCLN mRNA CTD PMID:29027214 OCLN Human diclofenac decreases expression ISO Ocln (Rattus norvegicus) 6480464 Diclofenac results in decreased expression of OCLN mRNA CTD PMID:29027214 OCLN Human Dictamnine multiple interactions EXP 6480464 [dictamnine co-treated with Oxygen deficiency] results in increased expression of OCLN protein more ... CTD PMID:30266538 OCLN Human diethyl phthalate multiple interactions ISO Ocln (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of OCLN protein CTD PMID:37364641 OCLN Human diiodine multiple interactions EXP 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein more ... CTD PMID:16514648 OCLN Human Diisodecyl phthalate multiple interactions ISO Ocln (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of OCLN protein CTD PMID:37364641 OCLN Human diisononyl phthalate multiple interactions ISO Ocln (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of OCLN protein CTD PMID:37364641 OCLN Human dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of OCLN mRNA CTD PMID:18661270 OCLN Human dioxygen multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Lipopolysaccharides promotes the reaction [Oxygen deficiency results in decreased expression of OCLN protein] more ... CTD PMID:23082119 OCLN Human dioxygen multiple interactions ISO Ocln (Mus musculus) 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN mRNA more ... CTD PMID:31816286 OCLN Human dioxygen multiple interactions EXP 6480464 [dictamnine co-treated with Oxygen deficiency] results in increased expression of OCLN protein more ... CTD PMID:30266538 and PMID:31816286 OCLN Human dioxygen decreases expression ISO Ocln (Rattus norvegicus) 6480464 Oxygen deficiency results in decreased expression of OCLN protein CTD PMID:23082119 OCLN Human dizocilpine maleate multiple interactions ISO Ocln (Mus musculus) 6480464 Dizocilpine Maleate inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of OCLN protein] CTD PMID:26655082 OCLN Human dodecanoic acid multiple interactions ISO Ocln (Mus musculus) 6480464 lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein] CTD PMID:34506767 OCLN Human dorsomorphin multiple interactions ISO Ocln (Mus musculus) 6480464 dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of OCLN protein] CTD PMID:33400020 OCLN Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OCLN mRNA CTD PMID:27188386 OCLN Human elemental selenium multiple interactions EXP 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein more ... CTD PMID:16514648 OCLN Human endosulfan decreases expression ISO Ocln (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of OCLN mRNA CTD PMID:31464424 OCLN Human epoxiconazole increases expression ISO Ocln (Mus musculus) 6480464 epoxiconazole results in increased expression of OCLN mRNA CTD PMID:35436446 OCLN Human ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of OCLN protein CTD PMID:25226407 OCLN Human ethanol multiple interactions ISO Ocln (Mus musculus) 6480464 [ethylene dichloride co-treated with Ethanol] results in decreased expression of OCLN mRNA more ... CTD PMID:30664321 more ... OCLN Human ethanol decreases expression ISO Ocln (Mus musculus) 6480464 Ethanol results in decreased expression of OCLN protein CTD PMID:31785310 and PMID:35639301 OCLN Human ethanol multiple interactions EXP 6480464 Ethanol results in decreased expression of and affects the localization of OCLN protein and Plant Extracts inhibits the reaction [Ethanol results in decreased expression of and affects the localization of OCLN protein] CTD PMID:28412402 OCLN Human ethanol affects localization EXP 6480464 Ethanol affects the localization of OCLN protein CTD PMID:22563376 and PMID:25226407 OCLN Human ethylene glycol decreases expression ISO Ocln (Rattus norvegicus) 6480464 Ethylene Glycol results in decreased expression of OCLN mRNA CTD PMID:37244400 OCLN Human excitatory amino acid agonist multiple interactions ISO Ocln (Mus musculus) 6480464 Dizocilpine Maleate inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of OCLN protein] CTD PMID:26655082 OCLN Human excitatory amino acid agonist decreases expression ISO Ocln (Mus musculus) 6480464 Excitatory Amino Acid Agonists results in decreased expression of OCLN protein CTD PMID:26655082 OCLN Human flutamide decreases expression ISO Ocln (Rattus norvegicus) 6480464 Flutamide results in decreased expression of OCLN mRNA CTD PMID:24136188 OCLN Human folic acid multiple interactions ISO Ocln (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of OCLN and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OCLN gene CTD PMID:20938992 OCLN Human FR900359 affects phosphorylation EXP 6480464 FR900359 affects the phosphorylation of OCLN protein CTD PMID:37730182 OCLN Human fulvestrant multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of OCLN gene more ... CTD PMID:19433574 and PMID:31601247 OCLN Human fulvestrant multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of OCLN mRNA] and Fulvestrant inhibits the reaction [Fulvestrant results in increased expression of OCLN mRNA] CTD PMID:19433574 and PMID:36931579 OCLN Human fumonisin B1 multiple interactions EXP 6480464 illite inhibits the reaction [fumonisin B1 results in decreased expression of OCLN mRNA] CTD PMID:27153755 OCLN Human fumonisin B1 decreases expression EXP 6480464 fumonisin B1 results in decreased expression of OCLN mRNA CTD PMID:27153755 OCLN Human furan decreases expression ISO Ocln (Mus musculus) 6480464 furan results in decreased expression of OCLN protein CTD PMID:32251705 OCLN Human furan multiple interactions ISO Ocln (Mus musculus) 6480464 rhodioloside affects the reaction [furan results in decreased expression of OCLN protein] CTD PMID:32251705 OCLN Human galactose decreases expression ISO Ocln (Mus musculus) 6480464 Galactose results in decreased expression of OCLN protein CTD PMID:33516661 OCLN Human gamma-linolenic acid multiple interactions EXP 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein more ... CTD PMID:16514648 OCLN Human genistein decreases expression EXP 6480464 Genistein results in decreased expression of OCLN mRNA CTD PMID:20816778 OCLN Human gentamycin decreases expression ISO Ocln (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of OCLN mRNA CTD PMID:33387578 OCLN Human Ginkgolide A multiple interactions ISO Ocln (Mus musculus) 6480464 ginkgolide A inhibits the reaction [Carbon Tetrachloride results in decreased expression of OCLN protein] CTD PMID:31697926 OCLN Human ginsenoside Re multiple interactions ISO Ocln (Mus musculus) 6480464 ginsenoside Re inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein] CTD PMID:22849695 OCLN Human glabridin multiple interactions ISO Ocln (Mus musculus) 6480464 [glabridin co-treated with Paclitaxel] results in increased expression of OCLN protein CTD PMID:37419298 OCLN Human glucose decreases expression EXP 6480464 Glucose results in decreased expression of OCLN mRNA and Glucose results in decreased expression of OCLN protein CTD PMID:21617913 more ... OCLN Human glucose multiple interactions EXP 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 OCLN Human glucose decreases expression ISO Ocln (Mus musculus) 6480464 Glucose results in decreased expression of OCLN protein CTD PMID:21617913 OCLN Human glycine decreases expression EXP 6480464 Glycine results in decreased expression of OCLN protein CTD PMID:30605748 OCLN Human glyphosate multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of OCLN protein] and NOX1 protein affects the reaction [Glyphosate results in decreased expression of OCLN protein] CTD PMID:34906888 OCLN Human glyphosate decreases expression ISO Ocln (Rattus norvegicus) 6480464 Glyphosate results in decreased expression of OCLN mRNA and Glyphosate results in decreased expression of OCLN protein CTD PMID:34906888 OCLN Human glyphosate decreases expression EXP 6480464 Glyphosate results in decreased expression of OCLN protein CTD PMID:30605748 OCLN Human hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of OCLN mRNA CTD PMID:18661270 OCLN Human hydrogen peroxide multiple interactions EXP 6480464 Quercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN protein] CTD PMID:20445016 OCLN Human hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of OCLN protein CTD PMID:20445016 OCLN Human hydrogen peroxide increases response to substance ISO Ocln (Mus musculus) 6480464 OCLN protein results in increased susceptibility to Hydrogen Peroxide CTD PMID:16982755 OCLN Human hydrogen peroxide multiple interactions ISO Ocln (Mus musculus) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [OCLN protein results in increased susceptibility to Hydrogen Peroxide] CTD PMID:16982755 OCLN Human hydrogen sulfide multiple interactions ISO Ocln (Mus musculus) 6480464 [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of OCLN protein more ... CTD PMID:33068716 OCLN Human hydroquinone multiple interactions ISO Ocln (Rattus norvegicus) 6480464 hydroquinone results in decreased degradation of and results in increased expression of OCLN protein CTD PMID:27587462 OCLN Human hydroxychloroquine increases expression EXP 6480464 Hydroxychloroquine results in increased expression of OCLN mRNA CTD PMID:25752684 OCLN Human hydroxysafflor yellow A multiple interactions ISO Ocln (Mus musculus) 6480464 hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in decreased expression of OCLN protein] CTD PMID:37001609 OCLN Human indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of OCLN mRNA CTD PMID:23668856 and PMID:29027214 OCLN Human indometacin multiple interactions ISO Ocln (Rattus norvegicus) 6480464 myricetin inhibits the reaction [Indomethacin results in decreased expression of OCLN mRNA] more ... CTD PMID:33276066 OCLN Human indometacin decreases expression ISO Ocln (Rattus norvegicus) 6480464 Indomethacin results in decreased expression of OCLN mRNA and Indomethacin results in decreased expression of OCLN protein CTD PMID:29027214 and PMID:33276066 OCLN Human indometacin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Indomethacin results in decreased expression of OCLN mRNA] CTD PMID:23668856 OCLN Human irinotecan decreases expression ISO Ocln (Mus musculus) 6480464 Irinotecan results in decreased expression of OCLN protein CTD PMID:38341106 OCLN Human irinotecan multiple interactions ISO Ocln (Mus musculus) 6480464 GSK484 inhibits the reaction [Irinotecan results in decreased expression of OCLN protein] and phenethyl isothiocyanate inhibits the reaction [Irinotecan results in decreased expression of OCLN protein] CTD PMID:38341106 OCLN Human iron atom multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Iron inhibits the reaction [Lead results in decreased expression of OCLN mRNA] and Iron inhibits the reaction [Lead results in decreased expression of OCLN protein] CTD PMID:17234227 OCLN Human iron(0) multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Iron inhibits the reaction [Lead results in decreased expression of OCLN mRNA] and Iron inhibits the reaction [Lead results in decreased expression of OCLN protein] CTD PMID:17234227 OCLN Human isoprene decreases expression EXP 6480464 isoprene results in decreased expression of OCLN protein CTD PMID:30236600 OCLN Human isovitexin multiple interactions ISO Ocln (Rattus norvegicus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [isovitexin inhibits the reaction [TNF protein results in decreased expression of OCLN protein]] and isovitexin inhibits the reaction [TNF protein results in decreased expression of OCLN protein] CTD PMID:37263555 OCLN Human kaempferol multiple interactions ISO Ocln (Mus musculus) 6480464 kaempferol inhibits the reaction [Ethanol results in decreased expression of OCLN protein] CTD PMID:31785310 OCLN Human kaempferol multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [kaempferol inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in decreased expression of OCLN protein CTD PMID:36049518 OCLN Human ketamine multiple interactions ISO Ocln (Mus musculus) 6480464 Ketamine inhibits the reaction [KNG1 protein results in increased expression of OCLN protein] CTD PMID:27638051 OCLN Human kynurenic acid multiple interactions ISO Ocln (Mus musculus) 6480464 Kynurenic Acid inhibits the reaction [lipopolysaccharide and E coli O55-B5 results in decreased expression of OCLN protein] CTD PMID:35123988 OCLN Human L-ascorbic acid multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein] CTD PMID:29940330 OCLN Human L-methionine multiple interactions ISO Ocln (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of OCLN and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OCLN gene CTD PMID:20938992 OCLN Human lactulose multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Lactulose inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of OCLN mRNA] and Lactulose inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of OCLN protein] CTD PMID:36414212 OCLN Human lead diacetate multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of OCLN protein] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of OCLN protein] CTD PMID:24200059 OCLN Human lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of OCLN protein CTD PMID:24200059 OCLN Human lead(0) multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [malaoxon co-treated with Lead] results in decreased expression of OCLN protein more ... CTD PMID:17234227 more ... OCLN Human lead(0) decreases expression ISO Ocln (Rattus norvegicus) 6480464 Lead results in decreased expression of OCLN mRNA and Lead results in decreased expression of OCLN protein CTD PMID:17234227 more ... OCLN Human lipopolysaccharide multiple interactions EXP 6480464 [2 more ... CTD PMID:22906770 and PMID:35774596 OCLN Human lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of OCLN protein CTD PMID:35774596 OCLN Human lipopolysaccharide increases expression ISO Ocln (Rattus norvegicus) 6480464 Lipopolysaccharides results in increased expression of OCLN protein CTD PMID:15763998 OCLN Human lipopolysaccharide multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [kaempferol inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in decreased expression of OCLN protein more ... CTD PMID:23082119 more ... OCLN Human lipopolysaccharide increases expression ISO Ocln (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of OCLN mRNA CTD PMID:12057914 OCLN Human lithium chloride increases expression ISO Ocln (Mus musculus) 6480464 Lithium Chloride results in increased expression of OCLN protein CTD PMID:33901603 OCLN Human lithium chloride decreases expression ISO Ocln (Mus musculus) 6480464 Lithium Chloride results in decreased expression of OCLN mRNA CTD PMID:33901603 OCLN Human lithocholic acid multiple interactions EXP 6480464 Lithocholic Acid inhibits the reaction [6-chloro-2 more ... CTD PMID:31472180 OCLN Human loliolide increases expression EXP 6480464 loliolide results in increased expression of OCLN protein CTD PMID:36707041 OCLN Human loliolide multiple interactions EXP 6480464 loliolide inhibits the reaction [CXCL12 protein results in decreased expression of OCLN protein] CTD PMID:36707041 OCLN Human luteolin multiple interactions EXP 6480464 Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of OCLN mRNA] and Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of OCLN protein] CTD PMID:33675858 OCLN Human LY294002 multiple interactions ISO Ocln (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [OCLN protein results in increased phosphorylation of IL1B protein] CTD PMID:15350541 OCLN Human LY294002 affects localization EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the localization of OCLN protein CTD PMID:19297429 OCLN Human LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of OCLN protein] CTD PMID:24200059 OCLN Human malaoxon decreases expression ISO Ocln (Rattus norvegicus) 6480464 malaoxon results in decreased expression of OCLN protein CTD PMID:20970449 OCLN Human malaoxon multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [malaoxon co-treated with Lead] results in decreased expression of OCLN protein CTD PMID:20970449 OCLN Human malathion multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [Malathion co-treated with Lead] results in decreased expression of OCLN protein CTD PMID:20970449 OCLN Human malathion decreases expression ISO Ocln (Rattus norvegicus) 6480464 Malathion results in decreased expression of OCLN protein CTD PMID:20970449 OCLN Human melatonin multiple interactions ISO Ocln (Mus musculus) 6480464 Melatonin inhibits the reaction [3 more ... CTD PMID:37598416 OCLN Human mercury atom decreases expression ISO Ocln (Mus musculus) 6480464 Mercury results in decreased expression of OCLN mRNA CTD PMID:37137463 OCLN Human mercury(0) decreases expression ISO Ocln (Mus musculus) 6480464 Mercury results in decreased expression of OCLN mRNA CTD PMID:37137463 OCLN Human methamphetamine multiple interactions ISO Ocln (Mus musculus) 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA] more ... CTD PMID:35390362 and PMID:36720452 OCLN Human methamphetamine decreases expression ISO Ocln (Mus musculus) 6480464 Methamphetamine results in decreased expression of OCLN mRNA and Methamphetamine results in decreased expression of OCLN protein CTD PMID:35390362 and PMID:36720452 OCLN Human methotrexate affects expression ISO Ocln (Mus musculus) 6480464 Methotrexate affects the expression of OCLN mRNA CTD PMID:18502557 OCLN Human methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of OCLN mRNA CTD PMID:29027214 OCLN Human methotrexate decreases expression ISO Ocln (Rattus norvegicus) 6480464 Methotrexate results in decreased expression of OCLN mRNA CTD PMID:29027214 OCLN Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of OCLN mRNA CTD PMID:21678067 OCLN Human methylmercury chloride decreases expression ISO Ocln (Rattus norvegicus) 6480464 methylmercuric chloride results in decreased expression of OCLN mRNA CTD PMID:34062221 OCLN Human methylmercury chloride multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Bee Venoms inhibits the reaction [methylmercuric chloride results in decreased expression of OCLN mRNA] CTD PMID:34062221 OCLN Human metronidazole multiple interactions ISO Ocln (Mus musculus) 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA] and [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein] CTD PMID:35390362 OCLN Human microcystin-LR decreases expression ISO Ocln (Mus musculus) 6480464 cyanoginosin LR results in decreased expression of OCLN protein CTD PMID:25986756 OCLN Human microcystin-LR decreases expression ISO Ocln (Rattus norvegicus) 6480464 cyanoginosin LR results in decreased expression of OCLN protein CTD PMID:27758031 OCLN Human minocycline increases expression ISO Ocln (Rattus norvegicus) 27095946 minocycline increases expression of occludin protein in left corpus callosum of rats with right carotid artery occlusion RGD OCLN Human mono(2-ethylhexyl) phthalate decreases expression ISO Ocln (Rattus norvegicus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of OCLN protein CTD PMID:18214902 OCLN Human mono(2-ethylhexyl) phthalate multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein] and mono-(2-ethylhexyl)phthalate results in decreased expression of and results in decreased localization of OCLN protein CTD PMID:29940330 and PMID:37941498 OCLN Human mono(2-ethylhexyl) phthalate affects localization ISO Ocln (Rattus norvegicus) 6480464 mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein CTD PMID:29940330 OCLN Human Monobutylphthalate decreases expression EXP 6480464 monobutyl phthalate results in decreased expression of OCLN protein CTD PMID:26922907 OCLN Human Monobutylphthalate decreases expression ISO Ocln (Rattus norvegicus) 6480464 monobutyl phthalate results in decreased expression of OCLN protein CTD PMID:18214902 OCLN Human mycophenolic acid decreases expression EXP 6480464 Mycophenolic Acid results in decreased expression of OCLN protein CTD PMID:35321622 OCLN Human mycophenolic acid multiple interactions EXP 6480464 schizandrin A inhibits the reaction [Mycophenolic Acid results in decreased expression of OCLN protein] CTD PMID:35321622 OCLN Human myricetin multiple interactions ISO Ocln (Rattus norvegicus) 6480464 myricetin inhibits the reaction [Indomethacin results in decreased expression of OCLN mRNA] and myricetin inhibits the reaction [Indomethacin results in decreased expression of OCLN protein] CTD PMID:33276066 OCLN Human N(6),N(6)-dimethyladenine multiple interactions ISO Ocln (Rattus norvegicus) 6480464 N(6) and N(6)-dimethyladenine promotes the reaction [Cadmium Chloride results in decreased expression of OCLN protein] CTD PMID:15618353 OCLN Human N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN mRNA] more ... CTD PMID:29235125 more ... OCLN Human N-acetyl-L-cysteine multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of OCLN protein] CTD PMID:34906888 OCLN Human N-acetyl-L-cysteine multiple interactions ISO Ocln (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [3 more ... CTD PMID:33485121 and PMID:37598416 OCLN Human N-acetylsphingosine decreases expression ISO Ocln (Mus musculus) 6480464 N-acetylsphingosine results in decreased expression of OCLN mRNA and N-acetylsphingosine results in decreased expression of OCLN protein CTD PMID:28052715 OCLN Human neomycin multiple interactions ISO Ocln (Mus musculus) 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA] and [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein] CTD PMID:35390362 OCLN Human nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of OCLN mRNA CTD PMID:25583101 OCLN Human nitric oxide decreases expression ISO Ocln (Rattus norvegicus) 6480464 Nitric Oxide deficiency results in decreased expression of OCLN protein CTD PMID:15763998 OCLN Human nitrofen increases expression ISO Ocln (Rattus norvegicus) 6480464 nitrofen results in increased expression of OCLN mRNA CTD PMID:33484710 OCLN Human Nor-9-carboxy-delta9-THC multiple interactions EXP 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of OCLN gene CTD PMID:30521419 OCLN Human obeticholic acid multiple interactions ISO Ocln (Mus musculus) 6480464 obeticholic acid inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein] and obeticholic acid promotes the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of OCLN protein] CTD PMID:35439472 and PMID:36720452 OCLN Human ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of OCLN mRNA CTD PMID:27153755 and PMID:30763683 OCLN Human ochratoxin A increases acetylation EXP 6480464 ochratoxin A results in increased acetylation of OCLN promoter CTD PMID:29098329 OCLN Human ochratoxin A multiple interactions EXP 6480464 illite affects the reaction [ochratoxin A results in decreased expression of OCLN mRNA] CTD PMID:27153755 OCLN Human okadaic acid increases expression EXP 6480464 Okadaic Acid results in increased expression of OCLN mRNA CTD PMID:30926360 OCLN Human p-tert-Amylphenol decreases expression ISO Ocln (Rattus norvegicus) 6480464 4-tert-octylphenol results in decreased expression of OCLN protein CTD PMID:15082077 OCLN Human paclitaxel multiple interactions ISO Ocln (Mus musculus) 6480464 [glabridin co-treated with Paclitaxel] results in increased expression of OCLN protein CTD PMID:37419298 OCLN Human papaverine decreases expression ISO Ocln (Rattus norvegicus) 6480464 Papaverine results in decreased expression of OCLN protein CTD PMID:20728510 OCLN Human paracetamol decreases expression ISO Ocln (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of OCLN mRNA CTD PMID:33387578 OCLN Human paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of OCLN protein CTD PMID:30698896 OCLN Human patulin increases degradation EXP 6480464 Patulin results in increased degradation of OCLN protein CTD PMID:19013514 OCLN Human patulin multiple interactions EXP 6480464 1 more ... CTD PMID:19013514 OCLN Human perfluorooctane-1-sulfonic acid multiple interactions ISO Ocln (Mus musculus) 6480464 Matrix Metalloproteinase Inhibitors inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of OCLN protein] and SB 203580 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of OCLN protein] CTD PMID:23761298 and PMID:27818224 OCLN Human perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 CID755673 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of OCLN protein] CTD PMID:36106993 OCLN Human perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of OCLN protein CTD PMID:32700164 and PMID:36106993 OCLN Human perfluorooctane-1-sulfonic acid decreases expression ISO Ocln (Mus musculus) 6480464 perfluorooctane sulfonic acid results in decreased expression of OCLN protein CTD PMID:23761298 and PMID:27818224 OCLN Human perfluorooctanoic acid decreases expression ISO Ocln (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of OCLN protein CTD PMID:25743374 and PMID:35066053 OCLN Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of OCLN protein CTD PMID:26879310 OCLN Human permethrin multiple interactions ISO Ocln (Mus musculus) 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein and Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] CTD PMID:29751049 OCLN Human phenethyl isothiocyanate multiple interactions ISO Ocln (Mus musculus) 6480464 phenethyl isothiocyanate inhibits the reaction [Irinotecan results in decreased expression of OCLN protein] CTD PMID:38341106 OCLN Human phenobarbital increases expression ISO Ocln (Mus musculus) 6480464 Phenobarbital results in increased expression of OCLN mRNA CTD PMID:19270015 OCLN Human phenobarbital affects expression ISO Ocln (Mus musculus) 6480464 Phenobarbital affects the expression of OCLN mRNA CTD PMID:23091169 OCLN Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of OCLN mRNA CTD PMID:19159669 OCLN Human phoxim multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Vitamin E inhibits the reaction [phoxim results in decreased expression of OCLN mRNA] CTD PMID:30003487 OCLN Human phoxim decreases expression ISO Ocln (Rattus norvegicus) 6480464 phoxim results in decreased expression of OCLN mRNA CTD PMID:30003487 OCLN Human pirinixic acid decreases expression ISO Ocln (Mus musculus) 6480464 pirinixic acid results in decreased expression of OCLN mRNA CTD PMID:18445702 OCLN Human poly(vinylpyrrolidone) affects expression EXP 6480464 Povidone affects the expression of OCLN mRNA CTD PMID:19729060 OCLN Human potassium dichromate decreases expression ISO Ocln (Rattus norvegicus) 6480464 Potassium Dichromate results in decreased expression of OCLN mRNA and Potassium Dichromate results in decreased expression of OCLN protein CTD PMID:28192182 OCLN Human potassium dichromate decreases expression ISO Ocln (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of OCLN protein CTD PMID:37146930 OCLN Human potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of OCLN protein CTD PMID:37146930 OCLN Human potassium dichromate multiple interactions EXP 6480464 AKT activator SC79 inhibits the reaction [Potassium Dichromate results in decreased expression of OCLN protein] and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [Potassium Dichromate results in decreased expression of OCLN protein] CTD PMID:37146930 OCLN Human potassium dichromate increases expression ISO Ocln (Rattus norvegicus) 6480464 Potassium Dichromate results in increased expression of OCLN protein CTD PMID:19766176 OCLN Human potassium iodide decreases expression ISO Ocln (Rattus norvegicus) 6480464 Potassium Iodide results in decreased expression of OCLN mRNA CTD PMID:32593569 OCLN Human pregnenolone 16alpha-carbonitrile decreases expression ISO Ocln (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in decreased expression of OCLN mRNA CTD PMID:19162173 OCLN Human PRIM-O-GLUCOSYLCIMIFUGIN affects localization EXP 6480464 prim-O-glucosylcimifugin affects the localization of OCLN protein CTD PMID:29910215 OCLN Human probenecid multiple interactions ISO Ocln (Mus musculus) 6480464 [Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 OCLN Human progesterone decreases expression ISO Ocln (Mus musculus) 6480464 Progesterone results in decreased expression of OCLN mRNA CTD PMID:22238285 OCLN Human propiconazole decreases expression ISO Ocln (Mus musculus) 6480464 propiconazole results in decreased expression of OCLN mRNA CTD PMID:21278054 OCLN Human puerarin multiple interactions EXP 6480464 puerarin inhibits the reaction [Sodium Chloride results in decreased expression of OCLN protein] and SIRT1 protein promotes the reaction [puerarin inhibits the reaction [Sodium Chloride results in decreased expression of OCLN protein]] CTD PMID:37865300 OCLN Human Pyridostigmine bromide multiple interactions ISO Ocln (Mus musculus) 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein and Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] CTD PMID:29751049 OCLN Human quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN protein] and Quercetin inhibits the reaction [Indomethacin results in decreased expression of OCLN mRNA] CTD PMID:20445016 and PMID:23668856 OCLN Human quercetin multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Quercetin inhibits the reaction [Indomethacin results in decreased expression of OCLN mRNA] and Quercetin inhibits the reaction [Indomethacin results in decreased expression of OCLN protein] CTD PMID:33276066 OCLN Human quercetin decreases expression ISO Ocln (Rattus norvegicus) 6480464 Quercetin results in decreased expression of OCLN mRNA and Quercetin results in decreased expression of OCLN protein CTD PMID:28431985 OCLN Human quercetin affects localization EXP 6480464 Quercetin affects the localization of OCLN protein modified form CTD PMID:19297429 OCLN Human quercitrin affects expression EXP 6480464 quercitrin affects the expression of OCLN mRNA CTD PMID:25193878 OCLN Human raloxifene multiple interactions EXP 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of OCLN mRNA CTD PMID:19059307 OCLN Human resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of OCLN mRNA CTD PMID:20816778 OCLN Human resveratrol multiple interactions ISO Ocln (Mus musculus) 6480464 Resveratrol inhibits the reaction [Aluminum Chloride results in decreased expression of OCLN mRNA] and Resveratrol inhibits the reaction [Aluminum Chloride results in decreased expression of OCLN protein] CTD PMID:34614429 and PMID:35156769 OCLN Human resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein] CTD PMID:32683294 OCLN Human rifampicin affects localization ISO Ocln (Mus musculus) 6480464 Rifampin affects the localization of OCLN protein CTD PMID:19577586 OCLN Human rotenone multiple interactions EXP 6480464 Rotenone inhibits the reaction [Particulate Matter results in decreased expression of OCLN protein] CTD PMID:28724416 OCLN Human rottlerin affects localization EXP 6480464 rottlerin affects the localization of OCLN protein modified form CTD PMID:19297429 OCLN Human Salidroside multiple interactions ISO Ocln (Mus musculus) 6480464 rhodioloside affects the reaction [furan results in decreased expression of OCLN protein] and rhodioloside inhibits the reaction [Streptozocin results in decreased expression of OCLN protein] CTD PMID:31682803 and PMID:32251705 OCLN Human SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein] and SB 203580 inhibits the reaction [Clopidogrel results in decreased expression of OCLN protein] CTD PMID:23220562 and PMID:32683294 OCLN Human SB 203580 multiple interactions ISO Ocln (Mus musculus) 6480464 SB 203580 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of OCLN protein] CTD PMID:23761298 and PMID:27818224 OCLN Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OCLN mRNA CTD PMID:27188386 OCLN Human selenium atom multiple interactions EXP 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein more ... CTD PMID:16514648 OCLN Human serpentine asbestos decreases expression EXP 6480464 Asbestos and Serpentine results in decreased expression of OCLN protein CTD PMID:30609805 OCLN Human simvastatin increases expression ISO Ocln (Rattus norvegicus) 6480464 Simvastatin results in increased expression of OCLN CTD PMID:18544044 OCLN Human sodium arsenite multiple interactions EXP 6480464 sodium arsenite affects the phosphorylation of and results in increased expression of OCLN protein CTD PMID:24349408 OCLN Human sodium arsenite decreases expression ISO Ocln (Mus musculus) 6480464 sodium arsenite results in decreased expression of OCLN mRNA and sodium arsenite results in decreased expression of OCLN protein CTD PMID:36100822 more ... OCLN Human sodium arsenite increases expression ISO Ocln (Mus musculus) 6480464 sodium arsenite results in increased expression of OCLN protein CTD PMID:37682722 OCLN Human sodium arsenite affects expression EXP 6480464 sodium arsenite affects the expression of OCLN mRNA CTD PMID:34032870 OCLN Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of OCLN mRNA CTD PMID:28595984 OCLN Human sodium arsenite multiple interactions ISO Ocln (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]] more ... CTD PMID:35381244 OCLN Human sodium arsenite affects localization ISO Ocln (Mus musculus) 6480464 sodium arsenite affects the localization of OCLN protein CTD PMID:24349408 OCLN Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of OCLN protein CTD PMID:24349408 OCLN Human sodium chloride decreases expression EXP 6480464 Sodium Chloride results in decreased expression of OCLN protein CTD PMID:37865300 OCLN Human sodium chloride multiple interactions EXP 6480464 puerarin inhibits the reaction [Sodium Chloride results in decreased expression of OCLN protein] and SIRT1 protein promotes the reaction [puerarin inhibits the reaction [Sodium Chloride results in decreased expression of OCLN protein]] CTD PMID:37865300 OCLN Human sodium fluoride decreases expression ISO Ocln (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of OCLN mRNA CTD PMID:27237588 OCLN Human sodium propionate multiple interactions ISO Ocln (Mus musculus) 6480464 sodium propionate inhibits the reaction [Ethanol results in decreased expression of OCLN protein] CTD PMID:35639301 OCLN Human sodium sulfide (anhydrous) multiple interactions ISO Ocln (Mus musculus) 6480464 [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of OCLN protein more ... CTD PMID:33068716 OCLN Human Soman decreases expression ISO Ocln (Rattus norvegicus) 6480464 Soman results in decreased expression of OCLN mRNA CTD PMID:19281266 OCLN Human streptozocin multiple interactions ISO Ocln (Mus musculus) 6480464 rhodioloside inhibits the reaction [Streptozocin results in decreased expression of OCLN protein] CTD PMID:31682803 OCLN Human streptozocin decreases expression ISO Ocln (Mus musculus) 6480464 Streptozocin results in decreased expression of OCLN protein CTD PMID:31682803 OCLN Human sulfasalazine multiple interactions ISO Ocln (Rattus norvegicus) 6480464 Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA] and Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein] CTD PMID:35290143 OCLN Human sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of OCLN mRNA CTD PMID:31533062 OCLN Human T-2 toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of OCLN mRNA and T-2 Toxin results in decreased expression of OCLN protein CTD PMID:27153755 and PMID:31170431 OCLN Human T-2 toxin multiple interactions EXP 6480464 illite inhibits the reaction [T-2 Toxin results in decreased expression of OCLN mRNA] CTD PMID:27153755 OCLN Human tamibarotene increases expression EXP 6480464 tamibarotene results in increased expression of OCLN mRNA CTD PMID:16982755 OCLN Human tamoxifen multiple interactions EXP 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of OCLN mRNA CTD PMID:19059307 OCLN Human tectorigenin multiple interactions ISO Ocln (Mus musculus) 6480464 tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of OCLN mRNA] and tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of OCLN protein] CTD PMID:35390440 OCLN Human telmisartan multiple interactions ISO Ocln (Mus musculus) 6480464 Telmisartan affects the reaction [LEPR protein affects the expression of OCLN mRNA] CTD PMID:34464088 OCLN Human telmisartan multiple interactions EXP 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 OCLN Human tert-butyl hydroperoxide decreases expression ISO Ocln (Rattus norvegicus) 6480464 tert-Butylhydroperoxide results in decreased expression of OCLN protein CTD PMID:34303734 OCLN Human testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of OCLN mRNA CTD PMID:33359661 OCLN Human tetrachloroethene increases expression ISO Ocln (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of OCLN mRNA CTD PMID:28973375 OCLN Human tetrachloromethane decreases expression ISO Ocln (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of OCLN protein CTD PMID:31697926 OCLN Human tetrachloromethane multiple interactions ISO Ocln (Mus musculus) 6480464 ginkgolide A inhibits the reaction [Carbon Tetrachloride results in decreased expression of OCLN protein] CTD PMID:31697926 OCLN Human thalidomide multiple interactions ISO Ocln (Mus musculus) 6480464 Thalidomide inhibits the reaction [dinitrobenzenesulfonic acid results in decreased expression of OCLN protein] CTD PMID:16680017 OCLN Human thioacetamide increases expression ISO Ocln (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of OCLN mRNA and Thioacetamide results in increased expression of OCLN protein CTD PMID:15350541 and PMID:23411599 OCLN Human thioacetamide multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of OCLN mRNA more ... CTD PMID:36414212 OCLN Human tioguanine decreases activity EXP 6480464 Thioguanine results in decreased activity of OCLN protein CTD PMID:17015055 OCLN Human titanium dioxide increases expression ISO Ocln (Mus musculus) 6480464 titanium dioxide results in increased expression of OCLN mRNA CTD PMID:23557971 and PMID:32333507 OCLN Human toluene increases expression ISO Ocln (Rattus norvegicus) 6480464 Toluene results in increased expression of OCLN mRNA CTD PMID:22967744 OCLN Human trichloroethene decreases expression ISO Ocln (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of OCLN mRNA CTD PMID:33387578 OCLN Human trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of OCLN mRNA CTD PMID:18661270 OCLN Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of OCLN mRNA CTD PMID:24935251 OCLN Human triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of OCLN mRNA CTD PMID:30510588 OCLN Human triphenyl phosphate decreases expression ISO Ocln (Mus musculus) 6480464 triphenyl phosphate results in decreased expression of OCLN mRNA CTD PMID:35752650 OCLN Human Triptolide decreases expression ISO Ocln (Mus musculus) 6480464 triptolide results in decreased expression of OCLN mRNA and triptolide results in decreased expression of OCLN protein CTD PMID:30836114 OCLN Human Triptolide multiple interactions ISO Ocln (Mus musculus) 6480464 mitoquinone inhibits the reaction [triptolide results in decreased expression of OCLN mRNA] and mitoquinone inhibits the reaction [triptolide results in decreased expression of OCLN protein] CTD PMID:30836114 OCLN Human troglitazone decreases expression ISO Ocln (Mus musculus) 6480464 troglitazone results in decreased expression of OCLN mRNA CTD PMID:28973697 OCLN Human uranium atom increases expression ISO Ocln (Rattus norvegicus) 6480464 Uranium analog results in increased expression of OCLN mRNA CTD PMID:27544493 OCLN Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of OCLN mRNA CTD PMID:19101580 OCLN Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OCLN mRNA CTD PMID:27188386 OCLN Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of OCLN mRNA CTD PMID:23179753 and PMID:26272509 OCLN Human vancomycin multiple interactions ISO Ocln (Mus musculus) 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA] and [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein] CTD PMID:35390362 OCLN Human vinclozolin increases methylation ISO Ocln (Rattus norvegicus) 6480464 vinclozolin results in increased methylation of OCLN gene CTD PMID:31682807 OCLN Human vitamin E multiple interactions ISO Ocln (Rattus norvegicus) 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein] and Vitamin E inhibits the reaction [phoxim results in decreased expression of OCLN mRNA] CTD PMID:29940330 and PMID:30003487 OCLN Human zafirlukast multiple interactions ISO Ocln (Mus musculus) 6480464 zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN mRNA] and zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN protein] CTD PMID:31816286 OCLN Human zafirlukast multiple interactions EXP 6480464 zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN mRNA] and zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN protein] CTD PMID:31816286 OCLN Human zileuton multiple interactions ISO Ocln (Mus musculus) 6480464 zileuton inhibits the reaction [dinitrobenzenesulfonic acid affects the localization of OCLN protein] CTD PMID:16670640 OCLN Human zinc sulfate multiple interactions EXP 6480464 Zinc Sulfate inhibits the reaction [Patulin results in increased degradation of OCLN protein] CTD PMID:19013514
